PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20067954-1 2010 OBJECTIVE: This trial tested whether mycophenolate mofetil (MMF) alone or with daclizumab (DZB) could arrest the loss of insulin-producing beta-cells in subjects with new-onset type 1 diabetes. Mycophenolic Acid 60-63 insulin Homo sapiens 121-128 11390035-9 2001 Additionally, alteration of insulin release from PIC cultured with PBMC or plastic-adherent cells was abolished dose-dependently (p < 0.0001 and p < 0.04, respectively) by gadolinium chloride (which inhibits macrophages), but not modified by cyclosporin A or mycophenolate mofetil which did not alter insulin release from PIC but blocked the proliferation of PBMC against PIC. Mycophenolic Acid 265-286 insulin Homo sapiens 28-35 34522770-0 2021 Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies. Mycophenolic Acid 0-21 insulin Homo sapiens 72-79 34522770-0 2021 Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies. Mycophenolic Acid 0-21 insulin Homo sapiens 101-108 33016111-3 2021 He was found to have anti-insulin antibodies and responded clinically to plasmapheresis and immunosuppression with mycophenolate mofetil (MMF)and prednisolone. Mycophenolic Acid 115-136 insulin Homo sapiens 26-33 33016111-3 2021 He was found to have anti-insulin antibodies and responded clinically to plasmapheresis and immunosuppression with mycophenolate mofetil (MMF)and prednisolone. Mycophenolic Acid 138-141 insulin Homo sapiens 26-33 27443993-2 2016 Immunosuppressive efficacies of glucocorticoids, calcineurin inhibitors, and mycophenolic acid are possibly affected by insulin after renal transplantation in these patients. Mycophenolic Acid 77-94 insulin Homo sapiens 120-127 27443993-4 2016 MATERIALS AND METHODS: Antiproliferative efficacies of prednisolone, hydrocortisone, cyclosporine, tacrolimus, and mycophenolic acid against concanavalin A-stimulated PBMCs were evaluated in the presence of physiological (5 muunits/mL) and super physiological (50 muunits/mL) concentrations of insulin. Mycophenolic Acid 115-132 insulin Homo sapiens 294-301 27443993-8 2016 The IC50 values of mycophenolic acid significantly increased by 50 muunits/mL insulin (p < 0.01). Mycophenolic Acid 19-36 insulin Homo sapiens 78-85 19500470-0 2009 Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Mycophenolic Acid 43-64 insulin Homo sapiens 87-94 19125765-3 2009 She was found to have circulating polyclonal anti-insulin antibodies of the IgG subtype and responded clinically to a course of plasma exchange and immunosuppression with mycophenolate mofetil and, subsequently, intravenous immunoglobulin. Mycophenolic Acid 171-192 insulin Homo sapiens 50-57 18709005-0 2008 Clinical importance of insulin resistance after renal transplantation in patients on triple immunosuppressive therapy with cyclosporine, corticosteroids and mycophenolate mofetil. Mycophenolic Acid 157-178 insulin Homo sapiens 23-30 15677500-3 2005 In this study, we report that tacrolimus, sirolimus, and mycophenolic acid, when added to cultures of freshly isolated human islets, induce a downregulation of the synthesis and secretion of insulin. Mycophenolic Acid 57-74 insulin Homo sapiens 191-198 18547238-1 2008 We have evaluated the use of the immunosuppressant mycophenolate mofetil (MMF) in the treatment of severe insulin resistance caused by neutralising anti-insulin antibodies in type 1 diabetes mellitus (T1DM). Mycophenolic Acid 51-72 insulin Homo sapiens 106-113 18547238-1 2008 We have evaluated the use of the immunosuppressant mycophenolate mofetil (MMF) in the treatment of severe insulin resistance caused by neutralising anti-insulin antibodies in type 1 diabetes mellitus (T1DM). Mycophenolic Acid 51-72 insulin Homo sapiens 153-160 18547238-1 2008 We have evaluated the use of the immunosuppressant mycophenolate mofetil (MMF) in the treatment of severe insulin resistance caused by neutralising anti-insulin antibodies in type 1 diabetes mellitus (T1DM). Mycophenolic Acid 74-77 insulin Homo sapiens 106-113 18547238-1 2008 We have evaluated the use of the immunosuppressant mycophenolate mofetil (MMF) in the treatment of severe insulin resistance caused by neutralising anti-insulin antibodies in type 1 diabetes mellitus (T1DM). Mycophenolic Acid 74-77 insulin Homo sapiens 153-160